Trending Stocks: Berkshire Hathaway, Southwest Airlines, Tyson Foods, More

Teva Pharmaceutical’s Revenue Declines but Still Beats Estimates

Shares of Teva Pharmaceutical Industries Ltd  (ADR) (NYSE:TEVA) have journeyed 4.73% into the green today after the company posted first quarter EPS of $1.20, down from $1.36 per share in the first quarter of 2015, but better than the estimates of $1.17. Revenue in the quarter also declined year-over-year, by 3.5% to $4.81 billion, but also surpassed the consensus projection of $4.77 billion. The Israeli-based drug maker faced a 17% decline in its generic drugs business as the company lost exclusivity of its proton pump inhibitor Esomeprazole and Crohn’s disease medicine budesonide.

Overall, 81 funds in our database were long Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) at the end of last year.

Southwest Airlines Posts Strong Traffic Statistics

Southwest Airlines Co (NYSE:LUV)’s stock has inclined by just under 1% today after the company reported impressive preliminary traffic statistics for April. The Texas-based airline company delivered 10.4 billion revenue passenger miles (RPMs) in April, showing a 4.7% increase from April 2015. Available seat miles (ASMs) increased by 4.3% year-over-year for the month, to 12.4 billion, while its load factor of 83.4% was its highest ever for April. A statement from the company said that based on these results, it expects a “modest increase” to its second quarter operating revenue per ASM (RASM) when compared with the second quarter of 2015.

David Harding’s Winton Capital Management was one of the 52 hedge funds in our system with positions in Southwest Airlines Co (NYSE:LUV) as of the end of 2015.

HCP, Inc Beats Revenue Estimates, Announces HCR ManorCare Spinoff

HCP, Inc. (NYSE:HCP) shares have surged by more than 4% today after the company posted first quarter earnings of $0.69 per share, in-line with analysts’ estimates, though down from $0.79 per share a year earlier. The real estate investment company’s revenue came in at $640.80 million, beating estimates of $621.93 million. For the full 2016 year, the company expects adjusted funds from operations (FFO) in the range of $2.77 to $2.83, while EPS is estimated to be between $1.80 and $1.86. HCP also announced today that its board has unanimously approved to spin-off its HCR ManorCare portfolio of skilled-nursing and assisted-living assets into a separately-traded real estate investment trust. The company said that this spinoff will help it focus on its core areas of senior housing and medical offices.

As of March 31, Ray Carroll’s Breton Hill Capital had 199,989 shares of HCP, Inc. (NYSE:HCP) in its portfolio.

Disclosure: None